| Financial Year |
March 31 2023 |
| Monetary Funds |
430,515,022.73 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
381,297,344.59 |
| Accounts Receivable |
1,089,652,445.12 |
| Advances to Suppliers |
788,314,552.90 |
| Other Receivables |
4,093,396.82 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,211,909,098.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
126,085,654.80 |
| Total Current Assets |
5,086,434,576.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
4,510,843,968.17 |
| Under-construction Projects |
1,429,776,720.33 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
370,020,113.50 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
10,342,177.57 |
| Deferred Income Tax Assets |
50,310,030.84 |
| Other Non-Current Assets |
265,000,777.61 |
| Sub-Total of Non-Current Assets |
7,266,549,410.35 |
| Total Assets |
12,352,983,986.45 |
| Short-Term Loans |
20,150,408.33 |
| Trading Financial liabilities |
-- |
| Notes Payable |
779,828,550.00 |
| Accounts Payable |
244,947,503.46 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
42,867,612.20 |
| Taxes Payable |
5,017,118.09 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
330,999,784.17 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
316,493,279.96 |
| Sub-Total of Current Liabilities |
1,832,097,093.68 |
| Long-term Loans |
725,191,692.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
72,910,375.22 |
| Other Non-Current Liabilities |
229,583.33 |
| Sub-Total of Non-Current Liabilities |
798,331,650.77 |
| Total Liabilities |
2,630,428,744.45 |
| Paid-In Capital(Or Share Stock) |
1,156,278,085.00 |
| Capital Surplus |
5,229,635,726.54 |
| Surplus Reserve |
467,375,294.32 |
| LESS:Treasury Stock |
162,774,692.45 |
| Undistributed Profits |
3,032,040,828.59 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,722,555,242.00 |
| Owner's Equity（Stockholder's Equity） |
9,722,555,242.00 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
12,352,983,986.45 |
